The FDA's announcement on February 21, 2025, declared the Semaglutide shortage resolved, triggering new restrictions on compounding (FDA Clarifies Policies for Compounders)
Descarga la ltima versin de nuestra app y actvalas para no perderte nuestro mejor contenido.
In another study done with 3,792 Covid patients from around the world, 7 months after contracting the illness, 78% reported fatigue, 57% reported cognitive dysfunction, and 68% were still unable to work
May relate to blood pressure effects in sensitive individuals
UK prescribers and patients now have substantial real-world experience with titration, injection technique, missed-dose rules, and follow-up, alongside the SURPASS trial programme that supported licensing